医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Curry Health Network Adopts ClickClean™ Advanced Laparoscopic Technology

2019年09月17日 PM10:00
このエントリーをはてなブックマークに追加


 

GOLD BEACH, Ore.

Curry Health Network, an integrated health care delivery system based in Gold Beach, Oregon, today announced that its flagship hospital, Curry General Hospital, has recently adopted the ClickClean™ advanced laparoscopic device, manufactured by Medeon Biodesign (Taipei, Taiwan). Adopting meaningful technologies that drive positive change and benefit patients directly is an integral part of Curry Health Network’s mission to promote healthy communities with efficient, quality health care, making ClickClean an ideal solution for its surgeons performing laparoscopy.

ClickClean provides physicians performing laparoscopic surgery a sustained clear view of the surgical area through a simple “click and clean” in-situ cleaning mechanism. This can significantly reduce the length of laparoscopic procedures, as well as reduce risks associated with obstructed vision, such as scope damage and procedure-associated infections.

“Having the ClickClean device with me during surgery has proven invaluable,” commented Curry Health Network’s (CHN) general surgeon, Jessica Carlson, M.D. “If you can’t see very well during a gall bladder surgery, for example, it makes the entire procedure about twice as difficult. To maintain a clear view, I used to have to remove and clean my surgical camera every 5 minutes. Now I can clean my camera lens with the click of a button, helping me stay focused on the surgery itself with less attention paid to camera maintenance. It’s an incredibly simple and useful technology that benefits me, and subsequently, my patients immensely.”

“Ensuring our patients have access to the latest surgical advancements is a key part of our mission,” added Virginia (Ginny) Williams, Chief Executive Officer of Curry Health Network. “We are always searching for technologies that help our physicians deliver better outcomes and improve safety wherever possible. Medeon’s philosophy – to deliver high-impact, high-value devices – aligns soundly with CHN’s mission, as we strive to put these types of technologies to work for our patients.”

About Curry Health Network

Curry Health Network is committed to providing high quality health care with service excellence, close to home. Curry Health Network is comprised of a hospital and several medical clinics located on the southern Oregon coast. Curry Health Network is an Oregon special health district, a form of local government and municipal corporation that has been granted 501(c)(3) status by the Internal Revenue Service.

For more information, visit www.CurryHealthNetwork.com.

About ClickClean™

ClickClean is a single use, disposable device that instantly restores a surgeon’s clarity of view in-situ with no scope removal required. The design sheathes the laparoscope and covers the lens with a clear film. As the visual field is soiled by blood and debris, a simple click will advance clean film over the distal end, giving the surgeon a clear unobstructed view. ClickClean is 510(k) cleared by the United States Food and Drug Administration (US-FDA) and has successfully demonstrated its simplicity, ease-of-use and clinical value in numerous clinical cases throughout the US.

For more information, visit www.clickclean-medeon.com.

About Medeon Biodesign

Medeon Biodesign is a publicly traded company located in Taipei, Taiwan, and currently listed on Taipei Exchange (TPEx: 6499). The company focuses on the development of high-impact, high-value medical devices that help treat diseases with sizable patient populations, such as cardiovascular, gastroenterology, gynecology, neurovascular, ophthalmology, orthopedic, peripheral vascular, and urology.

For more information, please visit www.medeonbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190917005297/en/

CONTACT

Cheryl McDermott

Curry Health Network

541-247-3192

cheryl.mcdermott@curryhealth.org

Genevieve Britton

Pascale Communications, LLC.

512.774.0735

genevieve@pascalecommunications.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report